SpyGlass Pharma, Inc. - Common Stock (SGP)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Mar 12, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 2.60 — trading above book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -15.9%
SpyGlass Pharma, Inc. - Common Stock (SGP) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $651 million . Key value metrics: P/B ratio 2.60, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
SpyGlass Pharma, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, SGP shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -15.9% (sector average: -20.6%).
StockPik's composite Value Score for SGP is 40/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SGP shows earnings declining at 37%.